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ABSTRACT 
OQectives: After more than 15 years without dengue activity, 
a dengue II epidemic was reported in Cuba in 1997. Three 
thousand and twelve serologically confirmed cases were 
reported, with 205 dengue hemorrhagic fever/dengue shock 
syndrome (DHF/DSS) cases and 12 fatalities. This report pre- 
sents the clinical, serologic, and virologic findings in the 12 
fatal DHF/DSS cases 
Methods: Serum and necropsy samples were studied by viral 
isolation in C636 cell line and polymerase chain reaction. Serum 
samples were tested by IgM capture enzyme-linked immuno- 
assay (ELISA) and ELISA inhibition method (EIM). 
Results: All 12 cases were classified as DHF/DSS according to 
the Pan American Health Organization Guidelines for Control 
and Prevention of Dengue and Dengue Hemorrhagic Fever in 
the Americas. All patients were older than 15 years. Women 
were more frequently affected. The symptoms and signs pre- 
sented by these patients were similar to those previously 
described in DHF/DSS cases. Clinical deterioration occurred on 
average at day 3.75. Abdominal pain and persistent vomiting 
were the earliest and most frequent warning signs. Dengue 
infection was confirmed in all cases. IgM antibodies were 
detected in 11 of 12 cases, all of them with a secondary infec- 
tion. Dengue II virus was detected by viral isolation in 12 sam- 
ples and by polymerase chain reaction in 17. Virus or RNA 
was detected in various tissues, including kidney, heart, lung, 
and brain. 
Conclusion: The clinical, pathologic, and laboratory features of 
12 cases of fatal dengue hemorrhagic fever were reviewed. 
The results obtained demonstrate that adults with a primary 
dengue infection are at risk of developing the severe disease 
(DHF) if they are infected with a different serotype. 
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After more than 15 years without dengue activity, a 
dengue II epidemic was reported in Cuba in 1997.’ In 
1977, a dengue fever (DF) outbreak caused by dengue I 
virus affected the whole country, with more than 500,000 
mild cases.’ A national serologic survey carried out in 
1981 showed that 44.46% of the population had anti- 
bodies to dengue viruses compared to the 2.6% seropos- 
itivity rate before the epidemic.3 In 1981, a second 
dengue epidemic was reported, with 344,203 cases; of 
these, 10,312 were clinically classified as dengue hem- 
orrhagic fever/dengue shock syndrome (DHF/DSS). There 
were 158 fatalities (101 children).* Dengue virus II was 
the etiologic agent. 
From 1982 to 1996 Cuba was free of dengue, owing 
to the effective campaign to control and eradicate Aedes 
degypti. Most of the 169 Cuban municipalities have been 
free of the vector. 
The high level of vector infestation, the increasing 
migration from dengue endemic areas, and the break- 
down of eradication measures caused by the critical 
Cuban economic situation resulted in the re-introduction 
of dengue in the municipality of Santiago de Cuba, in the 
eastern part of the country. This outbreak, detected in 
January 1997, was controlled by August and 3012 sero- 
logically confirmed cases were reported, with 205 
DHF/DSS cases (all in adults) and 12 fatalities. Secondary 
infection was detected in 98% of DHF/DSS cases. Dengue 
II virus (Jamaica genotype) was the etiologic agent.’ 
Secondary infections resulting in DHF/DSS (including 
fatalities) were observed for at least 16 years after the 
first dengue infection of this epidemic. This report pre- 
sents the clinical, serologic and virologic findings 
observed in the 12 fatal DHF/DSS cases of the 1997 
dengue II outbreak. 
MATERIALS AND METHODS 
Clinical Case Definition 
All cases were classified according to the Guidelines for 
Control and Prevention of Dengue and Dengue Hemor- 
rhagic Fever in the Americas.5 
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Specimens 
Serum specimens were obtained during the acute phase 
of the disease. Blood samples were drawn by venipunc- 
ture, and after centrifugation, serum was removed. Sam- 
ples were stored at -70°C. Necropsy samples were 
delivered to the reference laboratory at 4°C. A 10% 
suspension of the tissue specimens was prepared in 
minimum essential medium (MEM) containing 10% calf 
serum, 500 units of penicillin, and 500 kg streptomycin 
per milliliter. 
Viral Isolation 
Aedes albopictus cell line (C636/HT) was grown in MEM 
supplemented with 10% heated fetal bovine serum (56°C 
for 30 mm), 1% nonessential amino acids, and 1% gluta- 
mine solution 200 mM. Sera (diluted 1 : 30) and tissue 
supernatants were inoculated (100 FL) onto mlonolayers 
of cells grown in 24 plastic plaque wells. Following cen- 
trifugation for 1 hour at 2500 rpm at 33°C supernatants 
were discarded and 1 mL of culture medium with 2% 
fetal bovine serum was added. Cells were kept at 33°C 
and observed daily for viral cytopathic effect (CPE). Mono- 
layers that showed no CPE were tested by indirect 
immunofluorescent assay (IFA), using hyperimmune 
ascitic fluid to dengue II. Negative cultures were passed 
on the same cell line twice. Virus isolates were identified 
by IFA, using specific monoclonal antibodies against the 
four dengue serotypes. (Antibodies were donated by Dr. D. 
Gubler from Centers for Diseases Control and Prevention, 
Atlanta, Georgia.) 
Serologic Studies 
Serum samples were tested for dengue-specific IgM anti- 
body by IgM capture enzyme-linked immunoassay 
(ELISA).6 The presence of IgM antibodies is usually con- 
sidered presumptive evidence for a current dengue infec- 
tion, but was classified as confirmed for this study. Serum 
samples also were tested serologically by ELISA inhibi- 
tion method (EIM), using the method of Fernandez and 
Vazquez.’ Classification as primary and secondary infec- 
tion followed previously established criteria.8 
Molecular Studies 
RNA was extracted from supernatants of necropsy tissue 
homogenates, using the previously described acid-guani- 
dine isothiocyanate procedure, with minor modi- 
fications.9J0 DNA amplification was done according to 
Lanciotti et aL9 
RESULTS 
Twelve cases of DHF/DSS were fatal, according to clini- 
cal and anatomopathologic criteria.5 All of these patients 
were older than 15 years (mean = 40 y; range = 17-57 
y). There were five (41.6%) males and seven (58.3%) 
females. Four (33.3%) were white, six (50%) were of 
mixed race, and two (16.6%) were black. Six of the 
patients were reported to have had an underlying dis- 
ease (i.e., diabetes, Crohn’s disease, gastritis, asthma, sick- 
lemia, and duodenal ulcer). The disease was acute; on 
average, hospitalization occurred at 2.9 days of onset of 
fever, and worsening of the clinical picture and death 
occurred at 3.75 and 7.5 days, respectively. 
All 12 patients developed fever, headache, persistent 
vomiting, malaise, bleeding manifestations, and shock. 
Hemoconcentration was present in 11 (91.6%) patients, 
and thrombocytopenia in 10 (83.3%). Ascites was 
observed in 11 (91.6%) cases and abdominal pain in 10 
(83.3%). Hepatomegaly was detected in 8 (66.6%) patients 
and pleural effusion in 7 (58.3%). Coma and splenomegaly 
were rarely observed (2 and 3 cases, respectively). 
The occurrence of hemorrhagic manifestations is 
characterized in Table 1. Hematemesis was observed in 
Table 1. Main Hemorrhagic Manifestations in the Twelve Fatal Cases of Dengue Hemorrhagic Fever, Cuba 1997 
Patient Number 
Hemorrhagic Manifestations 1 2 3 4 5 6 7 8 9 10 II 12 
Petechiae (n = 5) x x X X X 
Hematemesis (n = 7) X X X X x X X 
Gum bleeding (n = 4) X X X X 
Nasal bleeding (n = 4) X X X X 
Venipuncture bleeding (n = 2) X X 
Pulmonary bleeding (n = 4) X X X* X 
Melena (n = 3) X X X 
Vaginal bleeding (n = 3) X X X 
Purpuric manifestations (n = 1) X 
Oral bleeding (n = 3) X X* X 
Ecchymosis (n = 3) X X X 
Hemoperitoneal bleeding (n = 2) X X* 
Conjunctival bleeding (n = 1) X 
Gastrointestinal bleeding (n = 1) X* 
*Findings at necropsy. 
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Table 2. Clinical Manifestations of Dengue Hemorrhagic Fever/Dengue Shock Syndrome Observed in Various Epidemics 
Percentage of Clinical Manifestation in Cases of DHF/DSS 
Clinical 1997 
Manifestation m 
Fever 100.0 
Vomiting 100.0 
Hepatomegaly 66.6 
Abdominal pain 83.3 
Ascites 91.6 
Pleural effusion 58.3 
Hemoconcentration 91.6 
Thrombocytopenia 83.3 
Shock 100.0 
Bleeding 100.0 
Petechiae 41.6 
Hematemesis 58.3 
Melena 25.0 
Vaginal bleeding 42.8 
*Cuban adults with DHF; iFatal DHF in Cuban adults. 
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seven (58.3%) cases; petechiae in five (41.6%); vaginal 
bleeding in three of seven females (42.8%); restlessness 
and hypotension in three (25%) cases; and sudden reduc- 
tion in temperature, profuse perspiration, tachycardia, 
and faintness in two (16.6%). In 58.3% of patients, warn- 
ing signs, of which abdominal pain and persistent vom- 
iting were the earliest and most frequent, were observed 
on the second or third day of onset. 
Table 2 shows a comparison of the main clinical 
manifestations observed in DHF/DSS cases during vari- 
ous epidemics.jallJz 
Dengue infection was confirmed in all cases by sero- 
logic, virologic, or molecular methods. IgM antibodies 
were detected in 11 (91.6%) of 12 cases, all of them with 
a secondary infection. The case with no IgM detected at 
day 4 had a titer of total immunoglobulin to dengue virus 
of 1:32O. Table 3 shows the main virologic and molecu- 
lar results. Dengue II virus was detected by viral isola- 
tion in 12 samples and by PCR in 17. Dengue II infection 
was confirmed in 10 cases. Virus or RNA was detected in 
the different tissues studied, including kidney, heart, lung, 
and brain. Dengue II was detected by both viral isolation 
Table 3. Virologic and Molecular Results on Samples 
from Fatal Cases of Dengue Hemorrhagic Fever 
Specimens 
Liver 
Spleen 
Kidney 
Brain 
Heart 
Lung 
Total 
viral isolation PCR 
Positive/Total (%) Positive/Total (%) 
5/l 0 (50.0) 9/l 0 (90.0) 
3/9 (33.3) 6/7 (85.7) 
l/3 (33.3) 2/2 (100.0) 
l/l (100.0) - 
l/3 (33.3) O/l - 
l/2 (50.0) O/l - 
12/28 (42.8) 17/21 (80.9) 
PCR = polymerase chain reaction. 
and PCR in a liver sample of the patient with no 
detectable IgM. 
DISCUSSION 
Dengue is the most important arthropod-borne viral infec- 
tion in man, and an estimated 50 to 100 million infec- 
tions occur annually, with over 60,000 fatalities to date 
from DHF.13-15 Currently, DF and DHF are emerging as 
important health problems in the tropics and especially 
in the American region, where the severe form of the 
disease has been recognized since 1981, when Cuba 
reported an extensive DHF epidemic2 
Excellent descriptions of the clinical spectrum of 
dengue virus infection and specifically DHF have been 
reported; however, most of these reports refer to clinical 
observations in children, because DHF has been observed 
mainly in this age group in southeast Asia.16J7 
Dengue hemorrhagic fever in adults in epidemic 
form was observed for the first time during the Cuban 
DHF epidemic of 1981. I1 Reports of DHF in individuals 
older than 15 years have progressively increased, mainly 
in the American region; however, few detailed reports 
describing the clinical, laboratory, and anatomicopatho- 
logic features have been published. 
During the 1997 Cuban DHF epidemic, 205 DHF 
cases were observed, all with serologic or virologic con- 
firmation.’ Of these, 12 patients died. The 12 fatal cases 
were classified as DHF according to the Guidelines for 
the Prevention and Control of Dengue and Dengue 
Hemorrhagic Fever in the American Region.5 Hemo- 
concentration was not detected in one case and 
thrombocytopenia was not detected in two cases, 
because the rapid and fatal outcomes precluded hema- 
tology studies. 
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For years, DHF has been considered a childhood dis- 
ease; however, in this study, the average age of patients 
(40 y) was different from that in previous reports.18z’9 
Reports of 1975 to 1978 from areas where DHF is 
endemic revealed only 8 of 629 patients in Indonesia and 
18 of 694 in Thailand to be older than 15 years.‘s,‘9 By 
contrast, in 1988, Diaz et al described the clinical picture 
of the disease in Cuban adults. More recently Zagne et al 
reported the presence of DHF in 56 adults in BrazilzO 
Currently, DHF is observed in both children and adults in 
Cuba. In the particular case of Cuba, only individuals who 
were born before 1981 are susceptible to a secondary 
infection (currently documented as the most important 
risk factor for DHF). Frequently, DHF has been reported 
among young girls over 4 years of age. In this study, 
females were affected more frequently than males. 
The symptoms and signs presented for these patients 
were similar to those previously described in DHF cases. 
In keeping with the observations made during the 1981 
Cuban epidemic,5~11~21~22 hepatomegaly, abdominal pain, 
ascites, hematemesis, and shock were relevant signs; how- 
ever, the high incidence of ascites in this epidemic could 
be attributable to the introduction of abdominal ultra- 
sound, which detects small amounts of fluid. 
Clinical deterioration occurred on average on day 
3.75, with a total disease course of 7 days. These data are 
similar to those described in some but not all reports.” 
It is important to point out that warning signs were 
observed in most cases at days 2 and 3; of these, abdom- 
inal pain and vomiting were the most frequently observed 
signs. The spectrum of these warning signs during the 
first 2 to 3 days of a febrile disease during a dengue epi- 
demic should alert clinicans to the possibility of DHF so 
that early and adequate life-saving treatment can be 
applied. 
Several risk factors for DHF related to the host, the 
vector, and the virus within an ecologic situation have 
been proposed; of these, sequential dengue infection is 
the most important. 23,24 A widely held explanatory 
hypothesis is that antibodies to any of the four dengue 
serotypes at subneutralizing concentrations, augment 
dengue virus infections of Fc receptor (FcR)positive cells, 
such as monocytes. Dengue virions and immunoglobulin 
G OgG) form virus-antibody complexes. The binding of 
immune complexes to FcR via the Fc portion of IgG 
results in augmentation of dengue virus infection. It is 
now known that primary dengue infections induce 
serotype-specific and serotype-cross-reactive CD4+ and 
CDS+ memory cytotoxic T lymphocytes (CTL). During 
secondary infections, the presence of cross-reactive non- 
neutralizing antibodies is thought to result in an increased 
number of monocytes that have been infected via dengue 
virus-antibody complexes. These cells activate serotype- 
cross-reactive CD4+ and CD8+ memory CTL, resulting in 
the rapid release of cytokines and chemical mediators 
that contribute to the plasma leakage and hemorrhage 
observed in DHF.25a26 Secondary infection, the virus 
serotype sequence of infections, and the characteristics 
of the strains also have been considered as possible risk 
factors for DHE 
In all but one of the fatalities during the 1997 Cuban 
epidemic, a secondary infection was demonstrated. This 
finding is in agreement with previous reports from Cuba 
and southeast Asia where secondary infection has been 
observed as the main risk factor for the severe dis- 
ease.11,21,23,24,27-29 In the current study, the sequence of 
infection was dengue I (in the 1977 dengue I epidemic) 
and dengue II (in the 1997 dengue II epidemic). This 
sequence of infection (dengue Vdengue II) is probably 
one of those most frequently associated with cases and 
epidemics of DHE23 Finally, both dengue II Cuban strains, 
one isolated during the 1981 DHF epidemic and the other 
isolated in the Santiago de Cuba outbreak (1997) have an 
Asian origin, demonstrated by genomic sequences. The 
first one (19Sl) is close to old dengue II strains, such as 
New Guinea C and 16681 strains, and the second (1997) 
is close to more recent strains, such as Jamaica 1982 and 
some related Thailand strains.30-32 
It was surprising how, after more than 17 years from 
the first infection, enhancing antibodies could still pro- 
duce the immunoenhancement phenomenon. This may 
be a unique and not previously reported observation. 
Bravo et al have suggested that the attack rate of DHF 
may be higher among whites than among other races.** 
They also reported that some chronic diseases, such as 
asthma, diabetes, and sicklemia, were risk factors for DHE 
Similar to the findings observed during the 1981 Cuban 
DHF epidemic, DHF again appeared to occur at a higher 
rate among whites. The ethnic population distribution of 
Santiago de Cuba is 30.1% whites, 26.8% mixed race, 
42.8% blacks, and 0.27% Asian; 33.3% of the fatal cases 
were among whites and only 16.6% among blacks, one 
of these was sicklemic (another DHF risk factor). 
Despite the fact that death occurred after deferves- 
cence and, thus, during the convalescent phase, dengue 
II virus was detected by PCR and viral isolation in 10 
cases. In the literature, rates of isolation of dengue virus 
from tissues of fatal cases are low, possibly owing to the 
presence of virus-neutralizing activity and the insensitiv- 
ity of the viral isolation systems.33 The use of the C636 
HT cell line and PCR may have contributed to the high 
isolation rate obtained in the present study. Liver is the 
tissue that most often yields virus isolation, although a few 
isolations have been obtained from other tissues.33 In the 
present study, viral antigen was detected in liver, spleen, 
brain, heart muscle, kidneys, and lung. In several cases, 
dengue II virus was recovered from tissues, suggesting 
that viral replication was occurring. 
It has been suggested that the central factor that deter- 
mines disease severity is the number of infected cells. The 
larger the number of infected cells, the more severe the 
illness. More specifically, DHF differs from DF because 
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there are more dengue virus-infected cells. Although the 
number of infected cells in the tissues of these patients 
is unknown, the presence of dengue II virus in different 
tissues in the same patient suggests widespread viral repli- 
cation with consequent tissue injury 
Similar to other reports, the most frequent gross 
anatomic fmdings at autopsy were Pete&al hemorrhages 
and an increase in extravascular fluid represented by effu- 
sions in serous cavities. Microscopically, generalized vas- 
cular damage was the most important histopathologic 
lesion (data not shown). 
Currently, DHF is emerging as an important health 
problem in the world and specifically in the American 
region. Annually, a high number of cases is reported even 
in countries without any antecedent reports of the dis- 
ease. The complete study of the Cuban DHF epidemics 
will allow researchers to learn about the epidemiology, 
clinical manifestations, and etiopatbogenesis of this severe 
disease. 
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